Uruguay Introduces New Marijuana Strain Épsilon in Pharmacies

Uruguay Introduces New Marijuana Strain Épsilon in Pharmacies

New Strain Joins the Legal Cannabis Lineup

Uruguay has taken another step in its progressive cannabis policy by allowing pharmacies to sell a new marijuana strain named Épsilon. This marks the fourth variant to be legally available, further expanding the options for consumers in the country. The introduction of Épsilon follows the legalization of marijuana under former President José Mujica’s administration in 2013, which set the stage for a regulated market.

What’s in Épsilon?

According to reports, Épsilon contains a tetrahydrocannabinol (THC) level of 20% or less, alongside a cannabidiol (CBD) content of 1% or less. THC is the psychoactive component responsible for the “high” associated with cannabis, while CBD is known for its therapeutic benefits without the intoxicating effects. The new strain joins existing options: Alpha and Beta, which have lower THC levels (9% or less), and Gamma, which has a THC level of 15% or less.

Sales Surge Following New Strain Release

The launch of the Gamma strain in December 2022 already spurred significant growth in the legal cannabis market, with registered users skyrocketing from 51,249 to 62,288 in under nine months. Sales figures reflect this trend, with marijuana sold increasing from 1,774 kilograms in 2022 to an impressive 3,258 kilograms in 2023. The growing acceptance and demand for cannabis in Uruguay highlight a shift in public perception towards the drug.

Political Controversy Surrounds Legalization

Despite the positive response from consumers, the decision to introduce Épsilon has faced criticism. Senator Guido Manini, a presidential candidate for the right-wing Cabildo Abierto party, expressed concerns on social media, labeling the state’s decision to sell marijuana as “irresponsible and criminal.” He emphasized the need for more education about the potential harms of drug use, questioning how the government plans to combat drug trafficking while promoting cannabis sales.

Comparing Cannabis to Wine

In defense of the new strain’s introduction, Daniel Radío, secretary of the National Drug Board of Uruguay, drew a parallel between the cannabis industry and wine production. He explained that while some individuals may grow their own grapes, the majority prefer to purchase wine from stores, where they have a variety of choices. This analogy underscores the government’s approach to treating cannabis as a regulated product rather than an illicit substance.

Limited Availability for Épsilon

The initial rollout of Épsilon will see limited quantities available in pharmacies, with plans for gradual market integration. The price for a five-gram package of Épsilon is set at 570 Uruguayan pesos, roughly equivalent to USD $13. This pricing strategy aims to keep the product accessible while managing supply as the market adjusts to the new strain.

Legal Framework for Cannabis in Uruguay

Uruguay’s cannabis framework allows not only for pharmacy purchases but also for home cultivation and membership in recognized cannabis-producing clubs. Currently, 71,843 citizens are registered to buy cannabis in pharmacies, while 11,708 have the legal right to grow it at home, and 13,687 belong to cannabis clubs. This multi-faceted approach reflects the country’s commitment to a comprehensive and regulated cannabis market.

Looking Ahead

As Uruguay continues to innovate in its cannabis policies, the introduction of Épsilon represents both an opportunity and a challenge. With rising sales and growing public acceptance, the nation is at the forefront of cannabis legalization in South America. However, the ongoing political discourse emphasizes the need for education and responsible use as the market evolves.

Trucker’s Job Loss Sparks Legal Battle Over CBD and THC Testing

Trucker’s Job Loss Sparks Legal Battle Over CBD and THC Testing

The Truth About CBD: What You Need to Know

The Truth About CBD: What You Need to Know